288 related articles for article (PubMed ID: 33970787)
1. Not so sweet and simple: impacts of SARS-CoV-2 on the β cell.
Ibrahim S; Monaco GSF; Sims EK
Islets; 2021 Jul; 13(3-4):66-79. PubMed ID: 33970787
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic β-cell fate in subjects with COVID-19.
Shirakawa J
J Diabetes Investig; 2021 Dec; 12(12):2126-2128. PubMed ID: 34529355
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells.
Coate KC; Cha J; Shrestha S; Wang W; Gonçalves LM; Almaça J; Kapp ME; Fasolino M; Morgan A; Dai C; Saunders DC; Bottino R; Aramandla R; Jenkins R; Stein R; Kaestner KH; Vahedi G; ; Brissova M; Powers AC
Cell Metab; 2020 Dec; 32(6):1028-1040.e4. PubMed ID: 33207245
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
[TBL] [Abstract][Full Text] [Related]
5. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
6. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.
Iwasaki M; Saito J; Zhao H; Sakamoto A; Hirota K; Ma D
Inflammation; 2021 Feb; 44(1):13-34. PubMed ID: 33029758
[TBL] [Abstract][Full Text] [Related]
7. Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2.
Jeremiah SS; Moin ASM; Butler AE
Metabolism; 2024 Jul; 156():155917. PubMed ID: 38642828
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 as a Trigger for Type 1 Diabetes.
Wang Y; Guo H; Wang G; Zhai J; Du B
J Clin Endocrinol Metab; 2023 Aug; 108(9):2176-2183. PubMed ID: 36950864
[TBL] [Abstract][Full Text] [Related]
10. Cytokine "storm", cytokine "breeze", or both in COVID-19?
Lippi G; Plebani M
Clin Chem Lab Med; 2020 Dec; 59(4):637-639. PubMed ID: 33554554
[No Abstract] [Full Text] [Related]
11. ACE2 function in the pancreatic islet: Implications for relationship between SARS-CoV-2 and diabetes.
Memon B; Abdelalim EM
Acta Physiol (Oxf); 2021 Dec; 233(4):e13733. PubMed ID: 34561952
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic
Fignani D; Licata G; Brusco N; Nigi L; Grieco GE; Marselli L; Overbergh L; Gysemans C; Colli ML; Marchetti P; Mathieu C; Eizirik DL; Sebastiani G; Dotta F
Front Endocrinol (Lausanne); 2020; 11():596898. PubMed ID: 33281748
[TBL] [Abstract][Full Text] [Related]
13. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 and pancreas: a potential pathological interaction?
Geravandi S; Mahmoudi-Aznaveh A; Azizi Z; Maedler K; Ardestani A
Trends Endocrinol Metab; 2021 Nov; 32(11):842-845. PubMed ID: 34373155
[TBL] [Abstract][Full Text] [Related]
15. Guillain Barré syndrome and COVID-19: Possible role of the cytokine storm.
Hussain FS; Eldeeb MA; Blackmore D; Siddiqi ZA
Autoimmun Rev; 2020 Dec; 19(12):102681. PubMed ID: 33099040
[No Abstract] [Full Text] [Related]
16. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
[TBL] [Abstract][Full Text] [Related]
17. Expression of SARS-CoV-2 receptor "ACE2" in human pancreatic β cells: to be or not to be!
El-Huneidi W; Hamad M; Taneera J
Islets; 2021 Sep; 13(5-6):106-114. PubMed ID: 34304698
[TBL] [Abstract][Full Text] [Related]
18. Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System.
Ernzen K; Trask AJ; Peeples ME; Garg V; Zhao MT
Stem Cell Rev Rep; 2021 Dec; 17(6):2107-2119. PubMed ID: 34365591
[TBL] [Abstract][Full Text] [Related]
19. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development.
Karnik M; Beeraka NM; Uthaiah CA; Nataraj SM; Bettadapura ADS; Aliev G; Madhunapantula SV
Mol Neurobiol; 2021 Sep; 58(9):4535-4563. PubMed ID: 34089508
[TBL] [Abstract][Full Text] [Related]
20. Before the "cytokine storm": Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications.
Dutta S; Mukherjee A; Nongthomba U
Cytokine Growth Factor Rev; 2022 Feb; 63():108-118. PubMed ID: 35039221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
